scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1013677905 |
P356 | DOI | 10.1038/SREP36359 |
P932 | PMC publication ID | 5099572 |
P698 | PubMed publication ID | 27821850 |
P50 | author | Paul Holvoet | Q79622441 |
Mohamed A Farag | Q88405178 | ||
Rasha S. Hanafi | Q44951055 | ||
P2093 | author name string | Sara E Ali | |
Mohamed Z Gad | |||
P2860 | cites work | HMDB 3.0--The Human Metabolome Database in 2013 | Q24595162 |
Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation | Q24597604 | ||
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease | Q24601951 | ||
Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease | Q26823796 | ||
A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance | Q28240815 | ||
The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener | Q28363080 | ||
XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification | Q29616057 | ||
Soft Corals Biodiversity in the Egyptian Red Sea: A Comparative MS and NMR Metabolomics Approach of Wild and Aquarium Grown Species. | Q30315551 | ||
Comparative metabolite profiling and fingerprinting of medicinal licorice roots using a multiplex approach of GC-MS, LC-MS and 1D NMR techniques. | Q30318182 | ||
Silent myocardial ischemia is associated with altered plasma phospholipids | Q33399462 | ||
Plasma Catecholamines and Carbohydrate Metabolism in Patients with Acute Myocardial Infarction | Q34464624 | ||
Pharmacokinetics of L-carnitine | Q34536074 | ||
Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study | Q34567266 | ||
Mechanisms linking obesity with cardiovascular disease | Q34590832 | ||
Expanding the limits of human blood metabolite quantitation using NMR spectroscopy | Q34879047 | ||
Analytical methods in untargeted metabolomics: state of the art in 2015. | Q35149924 | ||
Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome | Q35187726 | ||
Hydrogen sulfide inhibits macrophage-derived foam cell formation | Q50545651 | ||
Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats | Q51119493 | ||
Whole blood choline and plasma choline in acute coronary syndromes: prognostic and pathophysiological implications. | Q52925721 | ||
Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. | Q54524505 | ||
Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach | Q57577431 | ||
Probabilistic Networks of Blood Metabolites in Healthy Subjects As Indicators of Latent Cardiovascular Risk | Q58619035 | ||
Metabolomic Profile of Human Myocardial Ischemia by Nuclear Magnetic Resonance Spectroscopy of Peripheral Blood Serum | Q60546787 | ||
A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer | Q61780836 | ||
The search for a biomarker of cardiac ischemia | Q73160566 | ||
Diagnostic marker cooperative study for the diagnosis of myocardial infarction | Q77222242 | ||
Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease | Q78200195 | ||
The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation | Q80613445 | ||
Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system | Q82528556 | ||
Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods | Q83337102 | ||
Metabolomic identification of diagnostic plasma biomarkers in humans with chronic heart failure | Q87278576 | ||
Metabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunction | Q35606621 | ||
Role of the liver in the control of carbohydrate and lipid homeostasis | Q36020648 | ||
World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects | Q36934263 | ||
Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. | Q37020158 | ||
Application of metabolomics to cardiovascular biomarker and pathway discovery | Q37206431 | ||
Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogenesis | Q37285009 | ||
Plasma free H2S levels are elevated in patients with cardiovascular disease. | Q37328808 | ||
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease | Q37742798 | ||
Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart. | Q37831555 | ||
Metabolomics as a tool for cardiac research | Q37935537 | ||
LC-MS-based metabolomics in the clinical laboratory | Q37954839 | ||
Translating metabolomics to cardiovascular biomarkers | Q38028672 | ||
Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells | Q38347480 | ||
Volatiles and primary metabolites profiling in two Hibiscus sabdariffa (roselle) cultivars via headspace SPME-GC-MS and chemometrics | Q38825162 | ||
Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria | Q39784182 | ||
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? | Q40625534 | ||
Coronary circulatory dynamics before and after successful coronary angioplasty | Q41534021 | ||
Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat | Q42122753 | ||
Untargeted metabolic profiling reveals potential biomarkers in myocardial infarction and its application | Q44788707 | ||
Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol | Q44897133 | ||
Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease | Q44911499 | ||
Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus | Q45387926 | ||
Serum free L-carnitine in association with myoglobin as a diagnostic marker of acute myocardial infarction. | Q45824764 | ||
Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice | Q46260974 | ||
Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies | Q46533556 | ||
Integrated comparative metabolite profiling via MS and NMR techniques for Senna drug quality control analysis. | Q46788146 | ||
Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes | Q46833532 | ||
Metabolomic identification of novel biomarkers of myocardial ischemia | Q46847927 | ||
Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach | Q48271417 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
biomarker | Q864574 | ||
metabolomics | Q12149006 | ||
P304 | page(s) | 36359 | |
P577 | publication date | 2016-11-08 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction | |
P478 | volume | 6 |
Q42267058 | A preliminary analysis of volatile metabolites of human induced pluripotent stem cells along the in vitro differentiation |
Q92402692 | Differential Network Analysis Reveals Metabolic Determinants Associated with Mortality in Acute Myocardial Infarction Patients and Suggests Potential Mechanisms Underlying Different Clinical Scores Used To Predict Death |
Q57300054 | Hydrogen Sulfide (HS)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases |
Q92241149 | Metabolic Disturbances Identified in Plasma Samples from ST-Segment Elevation Myocardial Infarction Patients |
Q92602951 | Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention |
Q60918724 | NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort |
Q95642577 | NMR-based plasma metabolic profiling in patients with unstable angina |
Q38666324 | Novel Risk Stratification Assays for Acute Coronary Syndrome |
Q30313196 | Phytochemical Profiles and Antimicrobial Activities of Allium cepa Red cv. and A. sativum Subjected to Different Drying Methods: A Comparative MS-Based Metabolomics |
Q61804542 | Pilot study of myocardial ischemia-induced metabolomic changes in emergency department patients undergoing stress testing |
Q57492839 | Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease |
Q45950402 | Sniffer mice discriminate urine odours of patients with bladder cancer: A proof-of-principle study for non-invasive diagnosis of cancer-induced odours. |
Q42368418 | The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: An Overview with Update on Immunomodulation |
Search more.